Related Experiment Videos
Behavior modification and haloperidol in chronic facial pain.
Southern Medical Journal
|February 1, 1979
Summary
This study found that relaxation therapy combined with haloperidol effectively treated 12 patients with difficult facial pain. These patients had not responded to other therapies, suggesting a new treatment option for refractory cases.
Area of Science:
- Neurology
- Psychiatry
- Pain Management
Background:
- Facial pain encompasses various conditions, with neuralgiform and migrainous pain being a small subset.
- Myofascial connective tissue disorders, neuropathic pain from trauma, and idiopathic facial pain constitute larger patient groups.
- Psychophysiologic mechanisms influenced by personality factors are considered significant in non-neuralgiform, non-migrainous facial pain.
Observation:
- Patients with non-neuralgiform, non-migrainous facial pain are often challenging to treat.
- Previous therapies like behavior modification, hypnosis, and biofeedback have shown limited success in some cases.
- This study focused on 12 patients who did not respond to established therapies.
Findings:
- A combination of Jacobson's relaxation therapy and haloperidol demonstrated efficacy in the studied patient cohort.
- All 12 subjects who failed other treatments showed positive responses to this combined therapeutic approach.
- The study details patient characteristics and the specific treatment methodology employed.
Implications:
- This findings suggest a novel therapeutic strategy for refractory cases of non-neuralgiform, non-migrainous facial pain.
- The combination of relaxation techniques and haloperidol may offer a viable treatment option for patients with complex facial pain syndromes.
- Further research is warranted to explore the broader applicability and mechanisms of this treatment approach in managing challenging facial pain conditions.